ALEMTUZUMAB PK IN PEDIATRIC PATIENTS UNDERGOING REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT): TOWARD DOSE INDIVIDUALIZATION.
CLINICAL PHARMACOLOGY & THERAPEUTICS(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL PHARMACOLOGY & THERAPEUTICS(2017)